Courtagen Life Sciences Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Courtagen Life Sciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012907
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company’s products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equipments and mitochondrial panels. It also provides drug development services such as target discovery, validation, clinical development, clinical trials, decentralized test development, pre-clinical and clinical trial protocol and companion diagnostic services. Courtagen’s products are used in treatment of mitochondrial disorders, epilepsy and seizure disorders, and neuro-developmental disorders. The company serves patients and physicians. It operates in the US and Bermuda. Courtagen is headquartered in Woburn, Massachusetts, the US.

Courtagen Life Sciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Courtagen Life Sciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Courtagen Life Sciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Courtagen Life Sciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Courtagen Life Sciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Courtagen Life Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Courtagen Life Sciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Courtagen Life Sciences Raises USD20 Million in Venture Financing 10
Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11
Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 12
Courtagen Life Sciences To Raise Funds Through Venture Financing 13
Courtagen Life Sciences Secures US$8 Million In Series B Venture Financing 14
Partnerships 15
Courtagen Life Sciences Enters Into Licensing Agreement With Scienion For sciFlexArrayer Technology 15
Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 16
Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 17
Courtagen Life Sciences Enters Into Agreement With Raptor Pharma For Genetic Testing 18
Courtagen Life Sciences Enters Into Co-Development Agreement With Tetracore 19
MedTrust Online Enters Into Co-Development Agreement With Avantra Biosciences 20
Courtagen Life Sciences Inc – Key Competitors 21
Courtagen Life Sciences Inc – Key Employees 22
Courtagen Life Sciences Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Strategy And Business Planning 24
Jul 18, 2017: Courtagen Life Sciences Shifts Focus to its Medicinal Cannabis Genetics and Testing Business 24
Corporate Communications 25
May 03, 2016: Courtagen Life Sciences Adds Pediatric Neurologist, Ngoc Minh Le, M.D., to the Company’s Clinical Team 25
Legal and Regulatory 26
Jan 21, 2016: Courtagen Life Sciences Receives New York State Clinical Laboratory Approval 26
Product News 27
Mar 01, 2017: Courtagen Continues Menu Expansion with Launch of New Spotlight Gene Tests for Neuromuscular Disorders 27
Feb 03, 2017: Courtagen Launches 17 New Spotlight Gene Tests for Neurology and Endocrinology 28
Aug 25, 2016: U.S. Patent Granted for Courtagen’s Novel DREAM PCR Decontamination Technology 29
Other Significant Developments 30
Dec 02, 2016: Courtagen Life Sciences Partners with Certainty Health to Pioneer the First Collaborative Ecosystem for Neurological Disorders 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Courtagen Life Sciences Inc, Medical Equipment, Key Facts 2
Courtagen Life Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Courtagen Life Sciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Courtagen Life Sciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Courtagen Life Sciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Courtagen Life Sciences Inc, Deals By Market, 2011 to YTD 2017 8
Courtagen Life Sciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Courtagen Life Sciences Raises USD20 Million in Venture Financing 10
Courtagen Life Sciences Raises USD7.5 Million in Venture Financing 11
Courtagen Life Sciences Raises USD6.3 Million in Venture Financing 12
Courtagen Life Sciences To Raise Funds Through Venture Financing 13
Courtagen Life Sciences Secures US$8 Million In Series B Venture Financing 14
Courtagen Life Sciences Enters Into Licensing Agreement With Scienion For sciFlexArrayer Technology 15
Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 16
Courtagen Life Sciences Enters Into An Agreement With SimulConsult For Genome-Phenome Analyzer 17
Courtagen Life Sciences Enters Into Agreement With Raptor Pharma For Genetic Testing 18
Courtagen Life Sciences Enters Into Co-Development Agreement With Tetracore 19
MedTrust Online Enters Into Co-Development Agreement With Avantra Biosciences 20
Courtagen Life Sciences Inc, Key Competitors 21
Courtagen Life Sciences Inc, Key Employees 22
Courtagen Life Sciences Inc, Subsidiaries 23

★海外企業調査レポート[Courtagen Life Sciences Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hitachi Ltd (6501):企業の財務・戦略的SWOT分析
    Hitachi Ltd (6501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • University of Texas MD Anderson Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Ander …
  • Unico Sigorta A.S:企業の戦略・SWOT・財務分析
    Unico Sigorta A.S - Strategy, SWOT and Corporate Finance Report Summary Unico Sigorta A.S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Axelar AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Axelar AB (Axelar) is a drug development company that develops various novel anti-cancer treatments. The company lead drug candidateAXL1717 is used for the treatmentof non-small cell lung cancer. It also offers treatments for disease such as glioblastoma, sarcoma, malignant melanoma and mult …
  • Mitsubishi Electric Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Electric Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Electric Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • AIG Asia Pacific Insurance Pte. Ltd.:企業の戦略・SWOT・財務情報
    AIG Asia Pacific Insurance Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary AIG Asia Pacific Insurance Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • BB&T Corporation:企業のM&A・事業提携・投資動向
    BB&T Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BB&T Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • CardioFocus Inc-医療機器分野:企業M&A・提携分析
    Summary CardioFocus Inc (CardioFocus) is a medical device company that manufactures and distributes investigating disposable fiber optic catheters and endoscopic products. The company provides cardiofocus endoscopic ablation system that consists of balloon catheter, deflectable sheath introducer, en …
  • Altona Energy Plc:企業の戦略・SWOT・財務分析
    Altona Energy Plc - Strategy, SWOT and Corporate Finance Report Summary Altona Energy Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vietnam Electricity:企業の戦略的SWOT分析
    Vietnam Electricity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Insulet Corp (PODD):製薬・医療:M&Aディール及び事業提携情報
    Summary Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetic s. Omnipod system consists of a dispos …
  • South African Express Airways (Pty) Ltd:企業の戦略・SWOT・財務分析
    South African Express Airways (Pty) Ltd - Strategy, SWOT and Corporate Finance Report Summary South African Express Airways (Pty) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Mapfre Middlesea p.l.c.:企業の戦略・SWOT・財務分析
    Mapfre Middlesea p.l.c. - Strategy, SWOT and Corporate Finance Report Summary Mapfre Middlesea p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Applied Industrial Technologies, Inc.:戦略・SWOT・企業財務分析
    Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Alon USA Energy, Inc.:企業の戦略・SWOT・財務情報
    Alon USA Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alon USA Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Scotts Miracle-Gro Company (SMG):企業の財務・戦略的SWOT分析
    The Scotts Miracle-Gro Company (SMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Baker & McKenzie LLP:企業の戦略的SWOT分析
    Baker & McKenzie LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Lannett Company Inc (LCI):製薬・医療:M&Aディール及び事業提携情報
    Summary Lannett Company Inc (Lannett) is a pharmaceutical company. It develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms. The company offers generic pharmaceuticals for medical indications such as antibiotic, cardiovascular, c …
  • A. K. Capital Services Ltd (530499):企業の財務・戦略的SWOT分析
    A. K. Capital Services Ltd (530499) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Kahve Dunyasi:企業の戦略・SWOT・財務分析
    Kahve Dunyasi - Strategy, SWOT and Corporate Finance Report Summary Kahve Dunyasi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆